Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Video: Using Grasshopper & KUKA Robots in Architectural Design March 16, 2019 Applied Motion Products introduces STF Stepper Drives August 10, 2018 Gardasoft announces FP200 series of lighting controllers March 19, 2019